Aktuelle Rheumatologie
DOI: 10.1055/a-2593-1540
Übersichtsarbeit

IgG4-assoziierte Erkrankungen – Das komplexe Krankheitsbild, Organbeteiligung, Komplikationen

IgG4-related disease – the complex clinical presentation, organ involvement and complications
Thea Thiele
1   Rheumatology and Immunology, Hannover Medical School, Hanover, Germany
,
Torsten Witte
1   Rheumatology and Immunology, Hannover Medical School, Hanover, Germany
› Institutsangaben

Zusammenfassung

IgG4-assoziierte Erkrankungen sind seltene, entzündlich fibrosierende Systemerkrankungen mit vielgestaltigem Verlauf, die nahezu jedes Organsystem betreffen können. Zu den häufigen Manifestationen gehören eine Autoimmunpankreatitis, Lymphadenopathien, die Retroperitonealfibrose, eine entzündliche Orbitopathie sowie Beteiligungen der Speichel- und Tränendrüsen. Alle Manifestationen können isoliert oder in Kombination auftreten und stellen oft eine diagnostische Herausforderung dar, da sie sowohl maligne als auch andere entzündliche Erkrankungen imitieren können. Mittlerweile wurden 4 Cluster identifiziert, die die Hauptphänotypen darstellen. Komplikationen entstehen durch die progressive Fibrose, die zu irreversiblen Organschäden führen kann, die neben der medikamentösen Therapie auch ein chirurgisches Vorgehen notwendig machen können.

Abstract

IgG4-related diseases are rare, inflammatory fibrosing systemic diseases with a potentially complex course that can affect almost any organ system. Common manifestations include autoimmune pancreatitis, lymphadenopathies, retroperitoneal fibrosis, inflammatory orbitopathy and involvement of the salivary and lacrimal glands. These can occur alone or in combination and often pose a diagnostic challenge as they can mimic both malignant and other inflammatory diseases. Four clusters have been identified that represent the main disease phenotypes. Complications arise from progressive fibrosis, which can lead to irreversible organ damage that may require surgery in addition to immunomodulatory therapy.



Publikationsverlauf

Eingereicht: 14. Februar 2025

Angenommen: 22. April 2025

Artikel online veröffentlicht:
04. Juni 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Stone JH, Zen Y, Deshpande V. et al. IgG4-related disease. N Engl J Med 2012; 366: 539-551
  • 2 Kamisawa T, Zen Y, Pillai S. et al. IgG4-related disease. Lancet 2015; 385: 1460-1471
  • 3 Lin W, Lu S, Chen H. et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford) 2015; 54: 1982-1990
  • 4 Wallace ZS, Zhang Y, Perugino CA. et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 2019; 78: 406-412
  • 5 Czarnywojtek A, Agaimy A, Pietrończyk K. et al. IgG4-related disease: an update on pathology and diagnostic criteria with a focus on salivary gland manifestations. Virchows Arch 2024; 484: 381-399
  • 6 Maslinska M, Dmowska-Chalaba J, Jakubaszek M. The Role of IgG4 in Autoimmunity and Rheumatic Diseases. Front Immunol 2022; 12: 787422
  • 7 Goto H, Takahira M, Azumi A. et al. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 2015; 59: 1-7
  • 8 Kubota T, Moritani S, Katayama M. et al. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol 2010; 128: 577-584
  • 9 Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol 2013; 91: 694-700
  • 10 Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003; 98: 2811-2812
  • 11 Takuma K, Kamisawa T, Igarashi Y. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol 2011; 23: 80-87
  • 12 Uchida K, Okazaki K. Current status of type 1 (IgG4-related) autoimmune pancreatitis. J Gastroenterol 2022; 57: 695-708
  • 13 Kersten R, Trampert DC, Herta T. et al. IgG4-related cholangitis – a mimicker of fibrosing and malignant cholangiopathies. J Hepatol 2023; 79: 1502-1523
  • 14 Lee HE, Zhang L. Immunoglobulin G4-related hepatobiliary disease. Semin Diagn Pathol 2019; 36: 423-433
  • 15 Zen Y, Harada K, Sasaki M. et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?. Am J Surg Pathol 2004; 28: 1193-1203
  • 16 Herta T, Verheij J, Beuers U. IgG4-assoziierte Cholangitis – klinische Präsentation eines lange übersehenen Krankheitsbildes. Internist (Berl) 2018; 59: 560-566
  • 17 Razok A, Romero Noboa ME, Sami F. et al. IgG4-related disease and isolated retroperitoneal fibrosis: A narrative review. ARP Rheumatol 2023; 2: 155-157
  • 18 Liu Y, Zhu L, Wang Z. et al. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study. Rheumatology (Oxford) 2021; 60: 767-772
  • 19 Rossi GM, Rocco R, Accorsi Buttini E. et al. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 2017; 12: 287-299
  • 20 Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis 2016; 19: 1049-1055
  • 21 Wallace ZS, Deshpande V, Mattoo H. et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol 2015; 67: 2466-2475
  • 22 Arora K, Rivera M, Ting DT. et al. The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls. Histopathology 2019; 74: 688-698
  • 23 Nikiphorou E, Galloway J, Fragoulis GE. Overview of IgG4-related aortitis and periaortitis. A decade since their first description. Autoimmun Rev 2020; 19: 102694
  • 24 Marvisi C, Accorsi Buttini E, Vaglio A. Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases. Presse Med 2020; 49: 104018
  • 25 Pérez-García CN, Olmos C, Vivas D. et al. IgG4-aortitis among thoracic aortic aneurysms. Heart 2019; 105: 1583-1589
  • 26 Fragoulis GE, Evangelatos G, Tektonidou MG. Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature. Clin Rheumatol 2021; 40: 1167-1173
  • 27 Stan MN, Sonawane V, Sebo TJ. et al. Riedel's thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf) 2017; 86: 425-430
  • 28 Rotondi M, Carbone A, Coperchini F. et al. Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 2019; 180: R175-R183
  • 29 Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: An update. Mod Rheumatol 2019; 29: 231-239
  • 30 Tanaka T, Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis. Int J Urol 2020; 27: 387-394
  • 31 Chougule A, Bal A. IgG4-related inflammatory pseudotumor: A systematic review of histopathological features of reported cases. Mod Rheumatol 2017; 27: 320-325